67544-71-2

Usage

Uses

Used in Pharmaceutical Industry:
2-AMINO-8-METHOXY-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID is used as a pharmaceutical drug candidate for its potential pharmacological properties. Its structure and properties make it a promising candidate for the development of new medications to treat various diseases and conditions.
Used in Medicinal Chemistry Research:
2-AMINO-8-METHOXY-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID is used as a subject of research in the field of medicinal chemistry. Its unique structure and properties allow scientists to explore its potential applications and interactions with biological systems, contributing to the advancement of drug discovery and development.

InChI:InChI=1/C12H15NO3/c1-16-10-4-2-3-8-5-6-12(13,11(14)15)7-9(8)10/h2-4H,5-7,13H2,1H3,(H,14,15)

Upstream product

• 67544-72-3 3',4'-dihydro-8'-methoxyspiro2,5-dione 
• 5309-19-3 8-methoxy-2-tetralone 

Downstream Products

• 144646-22-0 2-benzamido-1,2,3,4-tetrahydro-8-methoxynaphthalene-2-carboxylic acid 
• 168628-99-7 C₁₉H₁₇NO₃ 
• 144646-46-8 N^2.2-<(R)-2-benzamido-1,2,3,4-tetrahydro-8-methoxynaphthalene-2-carbonyl>-L-phenylalanyl-L-phenylalanine N^1.3,N^1.3-(tetramethylene)amide 
• 144732-00-3 N^2.2-<(S)-2-benzamido-1,2,3,4-tetrahydro-8-methoxynaphthalene-2-carbonyl>-L-phenylalanyl-L-phenylalanine N^1.3,N^1.3-(tetramethylene)amide 
• 144646-31-1 methyl 2-benzamido-1,2,3,4-tetrahydro-8-methoxynaphthalene-2-carboxylate 
• 1221134-72-0 C₁₃H₁₇NO₃ 

Relevant academic research and scientific papers

SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS

In its many embodiments, the present invention provides a novel class of spiroaminooxazoline analogues as modulators of α2C adrenergic receptor, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.

BIARYL SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS

In its many embodiments, the present invention provides a novel class of biaryi spiroaminooxazoline analogues as modulators of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such c